Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.
about
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenovirusesCorticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemo- or radiotherapy, or surgery)Neurokinin-1 receptor antagonists for prevention of chemotherapy-related nausea and vomiting in adultsSerotonin receptor antagonists for highly emetogenic chemotherapy in adultsSerotonin receptor antagonists for highly emetogenic chemotherapy in adultsNeurokinin-1 receptor antagonists for prevention of chemotherapy-related nausea and vomiting in adultsTreating nausea and vomiting in palliative care: a reviewThe 5-HT3 receptor as a therapeutic targetDocetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trialNeurokinin-1 receptor antagonists for prevention of chemotherapy-related nausea and vomiting in adultsSystemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and managementBreast cancer in pregnancy: a literature review.Pattern of prophylaxis administration for chemotherapy-induced nausea and vomiting: an analysis of city-based health insurance data.Evaluation of outcomes in converting from intravenous ondansetron to oral granisetron: an observational study.Advances in use of the 5-HT3 receptor antagonists.The impact of cancer research: how publications influence UK cancer clinical guidelinesAntiemetics: American Society of Clinical Oncology clinical practice guideline update.Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation studyFosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomitingDaily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia.Aprepitant: the evidence for its place in the prevention of chemotherapy-induced nausea and vomiting.Insight in the prediction of chemotherapy-induced nausea.Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.Control of nausea and vomiting after chemotherapy: what is the evidence?Platinum drugs in the treatment of non-small-cell lung cancerChemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists.5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial.Electrocardiographic and cardiovascular effects of the 5-hydroxytryptamine3 receptor antagonists.Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutTreatment of non-pain-related symptoms.Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.Potential synergism between hypnosis and acupuncture—is the whole more than the sum of its parts?5-HT3 receptor antagonists for prevention of late acute-onset emesis.Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice.An assessment of chemotherapy-induced nausea and vomiting direct costs in three EU countries.Serum tumor markers in pediatric osteosarcoma: a summary review.Chemotherapy-Induced Nausea and Vomiting: Time for More Emphasis on Nausea?Employment of substandard antiemetic prophylaxis in recent trials of chemotherapy-induced nausea and vomiting.Clinical practice guidelines on antiemetics in oncology.Effects of a self-management program on antiemetic-induced constipation during chemotherapy among breast cancer patients: a randomized controlled clinical trial.
P2860
Q21144267-C5D2CC6F-D536-456A-B289-2C41C6E48217Q24187427-3473BBFA-B653-4544-8D05-C58EF8DB8140Q24200792-90DDD2E9-08B1-4358-8284-E05A32CFC9CDQ24202033-1C0B0CDD-2BC3-496A-B5B4-69308BD16CB7Q24240511-9391D747-0126-4B81-9AB2-9A61A0C83D02Q24243745-5513FCCD-AFEB-43F4-B3C0-4B53FC8E3450Q24635649-F7D4C896-C3A3-450D-A3DC-33AE3078BBDAQ24681066-34468FF6-1F2D-42EC-9F7E-AC2D23E3D83CQ24799659-882BD2E7-6699-4DE5-92A4-2D57FFE09718Q26472106-BA2D62BB-34E3-41EC-AE02-CE068CBC0DE5Q26830695-ECFA6E55-1BD8-451E-907D-D30DFFC4E7F0Q30423563-69AA96EC-06C1-403B-AF52-BB4F8A458D17Q30570659-B4B8CDB6-3FC9-47F3-A5BE-3C10C64F5FAEQ31989474-82142E9C-7057-41B9-B060-6DEFF4CB2958Q33181781-18C2C859-61FB-4D80-BFB7-7237267E47EBQ33339897-4F739629-8221-413D-BD55-022BF2BCDA7EQ34030613-3B521E7C-7DF4-4194-AF78-DC14DB67A99EQ34204650-D1636F81-8AA2-495F-BB23-7C575729AC1AQ34239808-B7BFCC7C-1E47-47B7-A40B-A74C3D048860Q34289628-F35F110D-8BAF-4958-BAAB-766B8FE10D3EQ34450534-1E5344B8-BA80-4239-AD0F-69A2481AD014Q34472901-BDCB4DCB-B825-426C-AC0C-C5BECB662B66Q34626554-2F1772DC-F19C-4A9D-B1CE-EA7D9DB64D82Q34773714-6379C86D-944F-4B53-9F3C-2FC9BB771303Q34954760-5A73C961-9631-44DA-B388-35EA54A4058FQ35076343-B5696EE2-1371-45FB-90E2-4A38F3A03044Q35146420-95113CBA-E5F7-4933-B9C2-9264D5DB43BDQ35201044-46B336B8-42EF-4E7E-B88F-2FA08BBE0236Q35236769-548594D9-9CBB-4D85-AE73-6828958F9466Q35611996-16724FE1-D47C-4F2F-9EDA-016450B1C14CQ35779340-BC3C1288-C482-460A-B018-834EA5820F60Q35809054-344F3699-5398-4BE4-8B3D-C25C505067F5Q35865448-B7EAABFC-C857-4188-A4E5-9D34B8D4535CQ35871611-C78B5500-97E6-4496-9307-0BB060A57833Q35980236-FF3F8512-5EF0-409E-80A2-4CFFE4AB9FE3Q35984687-EE7DBD5A-5A2E-4A97-8987-41E6736B82DBQ36064834-FB450312-8A45-4CF2-805D-C1C9C1D0811FQ36276557-E649E6F8-DB04-40A7-A1FC-7B44D4EC067CQ36334870-EB3C68AE-3581-4D3C-9F66-0C81A60A9906Q36441640-6A2523E6-D220-4F86-BAD0-2CD2F208BBA6
P2860
Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Recommendations for the use of ...... Society of Clinical Oncology.
@ast
Recommendations for the use of ...... Society of Clinical Oncology.
@en
type
label
Recommendations for the use of ...... Society of Clinical Oncology.
@ast
Recommendations for the use of ...... Society of Clinical Oncology.
@en
prefLabel
Recommendations for the use of ...... Society of Clinical Oncology.
@ast
Recommendations for the use of ...... Society of Clinical Oncology.
@en
P2093
P1476
Recommendations for the use of ...... Society of Clinical Oncology.
@en
P2093
D G Pfister
G R Morrow
J H Silber
J M Koeller
L W Chinnery
P J Hesketh
P304
P356
10.1200/JCO.1999.17.9.2971
P407
P577
1999-09-01T00:00:00Z